ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2022

Developing a Gout Needs Assessment Incorporating Patient Perspective on  Self-Management, Self-Efficacy and Disease Specific Knowledge, to Inform a Patient Education Initiative

Adam Rifaat1, Adena Batterman2, Roberta Horton2 and Theodore R. Fields1, 1Rheumatology, Hospital for Special Surgery, New York, NY, 2Social Work Programs, Hospital for Special Surgery, New York, NY

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: gout, patient preferences and self-management

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2016

Title: ARHP III: Education and Community Programs

Session Type: ARHP Concurrent Abstract Session

Session Time: 2:30PM-4:00PM

Background/Purpose: Gout is the most common inflammatory arthritis in adults, with great impact on quality of life. Despite excellent therapeutic options, outcomes remain suboptimal. Research supports the need for patient-centered education interventions as an integral part of effective gout management. While studies have demonstrated that provider-created knowledge assessments can be a first-step in designing patient education interventions, they have not typically included patient identified needs. This is especially important since gout patients need assistance in diet and lifestyle change in addition to urate management. We developed a needs assessment which inquired about patient perspective and self-efficacy re: gout self-management. Our purpose was to identify disease–specific knowledge gaps and patient-identified concerns, to ensure their inclusion in a patient education initiative for gout patients.

Methods: We developed a 26-item needs assessment, including Likert & open-ended questions to assess patient self-efficacy around essential gout-related knowledge and patient-identified needs to enhance self-management. Knowledge-based questions were derived from evidence-based clinical guidelines re: gout treatment and lifestyle changes and data from our concurrent gout patient education study. Potential participants (357) were treated for gout by rheumatologists in an ambulatory clinic or private office and approached either in person or by mail.

Results: One hundred questionnaires were completed, with a return rate of 42/294 (14%) by mail and 58/63 (92%) in-person. Mean yrs since diagnosis: 10.8; M74%, F26%; mean age: 64 yrs; Race/Ethnicity: White 78% Asian 12% African American 7% Latino 2%. Completed college or above: 79%. In the preceding 6 months 13.4% had >3 flares; of these, 33% felt their gout was “under control.” Fifty-four % of respondents did not know “how often to have uric acid checked”; in patients with >3 flares in past 6 months , 77% did not know; 29% did not know their uric acid goal; 51% of all respondents did not know “how to manage side-effects of medications.” When asked about purpose of bridge therapy, 60% were unsure or did not answer; 55% did not answer or didn’t know when they should discontinue bridge therapy. When asked about “information of most interest [to them]”, most frequent response was diet guidelines; 83% wanted to hear from an MD; 61% from a nutritionist.

Conclusion: Even in a highly educated sample of rheumatologist-treated gout patients with a mean diagnosis of 10.8y, we found major patient knowledge gaps in essential gout-related self-management skills. Core findings include gaps related to: uric acid goals, frequency of testing, bridge therapy and outcome expectations. In open-ended questions, patients stated a desire for more information about diet guidelines, and input from a nutritionist. Our results are consistent with prior studies showing large gaps in critical gout patient knowledge, which are likely associated with widely reported poor gout patient outcomes. Our data informed the content of an educational symposium for gout patients and may be of use to others involved in enhancing self-management and improving outcomes for gout patients.


Disclosure: A. Rifaat, None; A. Batterman, None; R. Horton, None; T. R. Fields, Advisory Board, speaker's bureua: Takeda Pharmaceuticals, 9,Advisory board: Astrazenica Pharmaceuticals, 5.

To cite this abstract in AMA style:

Rifaat A, Batterman A, Horton R, Fields TR. Developing a Gout Needs Assessment Incorporating Patient Perspective on  Self-Management, Self-Efficacy and Disease Specific Knowledge, to Inform a Patient Education Initiative [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/developing-a-gout-needs-assessment-incorporating-patient-perspective-on-self-management-self-efficacy-and-disease-specific-knowledge-to-inform-a-patient-education-initiative/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/developing-a-gout-needs-assessment-incorporating-patient-perspective-on-self-management-self-efficacy-and-disease-specific-knowledge-to-inform-a-patient-education-initiative/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology